On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction

B. J. A. Mertens*, Y. E. M. van der Burgt, Berit Velstra, W. E. Mesker, R. A. E. M. Tollenaar, A. M. Deelder

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

We consider a proteomic mass spectrometry case-control study for the calibration of a diagnostic rule for the detection of early-stage breast cancer. For each patient, a pair of two distinct mass spectra is recorded, each of which is derived from a different prior fractionation procedure on the available patient serum. We propose a procedure for combining the distinct spectral expressions from patients for the calibration of a diagnostic discriminant rule. This is achieved by first calibrating two distinct prediction rules separately, each on only one of the two available spectral data sources. A double cross-validatory approach is used to summarize the available spectral data using the two classifiers to posterior class probabilities, on which a combined predictor can be calibrated. © 2011 Elsevier B.V.

Original languageEnglish
Pages (from-to)759-766
Number of pages8
JournalStatistics & probability letters
Volume81
Issue number7
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Keywords

  • Clinical mass spectrometry proteomics
  • Predictive data fusion
  • Double cross-validation
  • Classification
  • Model combination
  • MALDI-TOF
  • SPECTROMETRY

Fingerprint

Dive into the research topics of 'On the use of double cross-validation for the combination of proteomic mass spectral data for enhanced diagnosis and prediction'. Together they form a unique fingerprint.

Cite this